This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
March 6, 2013 /PRNewswire/ -- X-Change Corp. (NASDAQ OTC: XCHC), a U.S. Company specializing in cannabinoid formulation-based health solutions through its Phytiva brand product lines announces, plans to develop and open cannabis medical treatment centers in
California, and other U.S. and international markets where existing law permits.
X-Change Corporation is proud to announce the commencement of plans to facilitate the opening of its first treatment center in Colorado. The paramount focus of this clinic will be treating several different types of cancer but will address other ailments as well. The Company is in the process of recruiting in-house experts for clinics and organic research consistent with
Colorado's new legal framework.
In addition to the servicing of people with these ailments, the Company plans for this medical center to collect vital data with regard to objective and scientifically based analysis of the progress of patients that can be used to further develop the Company's formulations and treatment protocols.
X-Change Corp's focus will be on its strategic alliances in
California, and states where the Company can participate in the initiation of operations and conduct business in full legal compliance with like-minded partners that have been issued the legal authority from their local jurisdictions to commence these important treatment activities. Simultaneously, the Company's broader goal is to focus on other countries that are friendly to similar business models, such as
Germany, and other European markets, before moving into Asian and Latin American markets in the mid and long term.
The Company is proud to be working with a wide range of master growers and entrepreneurs who support the mission of meeting the needs of their communities with products based on proven cannabinoid science, as well as of advocating for patient rights throughout the world.